Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury

INTRODUCTION: The clinical course of coronavirus 2019 (COVID-19) is heterogeneous, ranging from mild to severe multiorgan failure and death. In this study, we analyzed cell-free DNA (cfDNA) as a biomarker of injury to define the sources of tissue injury that contribute to such different trajectories...

Descripción completa

Detalles Bibliográficos
Autores principales: Andargie, Temesgen E., Tsuji, Naoko, Seifuddin, Fayaz, Jang, Moon Kyoo, Yuen, Peter S.T., Kong, Hyesik, Tunc, Ilker, Singh, Komudi, Charya, Ananth, Wilkins, Kenneth, Nathan, Steven, Cox, Andrea, Pirooznia, Mehdi, Star, Robert A., Agbor-Enoh, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119224/
https://www.ncbi.nlm.nih.gov/pubmed/33651717
http://dx.doi.org/10.1172/jci.insight.147610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119224/
https://www.ncbi.nlm.nih.gov/pubmed/33651717
http://dx.doi.org/10.1172/jci.insight.147610

Ejemplares similares